Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kern

Showing results (261-270 of 388) with videos related to

Pageof 39
Sort By:
International Forum of Allergy & Rhinology|January 29, 2026
Appropriate Medical Therapy Primarily Modifies Type 2 and Severity Biomarkers in Chronic RhinosinusitisAsher C Park, Brooke N Gleason, Eli Stein, et al.
BMC Health Services Research|May 20, 2025
Sex differences in healthcare utilization for chronic rhinosinusitis: a prospective cohort studyAnnemarie G Hirsch, Brian S Schwartz, Cara M Nordberg, et al.
American Journal of Rhinology & Allergy|March 16, 2019
Procalcitonin as a Biomarker in Rhinosinusitis: A Systematic ReviewAmanda E Dilger, Anju T Peters, Richard G Wunderink, et al.
Allergy|September 3, 2015
Five-year risk of incident disease following a diagnosis of chronic rhinosinusitisA G Hirsch, X S Yan, A S Sundaresan, et al.
The American Journal of Cardiology|May 6, 2023
Cardiology Care and Loss to Follow-Up Among Adults With Congenital Heart Defects in CH STRONGJennifer G Andrews, Danielle Strah, Karrie F Downing, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophreniaSean M Smith, Dawn Toolan, Monika Kandebo, et al.
International Forum of Allergy & Rhinology|March 17, 2021
Responsiveness and convergent validity of the chronic rhinosinusitis patient-reported outcome (CRS-PRO) measure in CRS patients undergoing endoscopic sinus surgeryKatherine A Lin, Caroline P E Price, Julia H Huang, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulatorsJeffrey C Kern, Eugene A Terefenko, Andrew Fensome, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 31, 2017
The Clinical Significance of Specific Antibody Deficiency (SAD) Severity in Chronic Rhinosinusitis (CRS)Anjeni Keswani, Neha M Dunn, Angelica Manzur, et al.
Cancer|August 8, 2008
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care centerNarissa J Nonzee, Neal A Dandade, Urjeet Patel, et al.
Pageof 39

Showing results (261-270 of 388) with videos related to

Sort By:
Pageof 39
International Forum of Allergy & Rhinology|January 29, 2026
Appropriate Medical Therapy Primarily Modifies Type 2 and Severity Biomarkers in Chronic RhinosinusitisAsher C Park, Brooke N Gleason, Eli Stein, et al.
BMC Health Services Research|May 20, 2025
Sex differences in healthcare utilization for chronic rhinosinusitis: a prospective cohort studyAnnemarie G Hirsch, Brian S Schwartz, Cara M Nordberg, et al.
American Journal of Rhinology & Allergy|March 16, 2019
Procalcitonin as a Biomarker in Rhinosinusitis: A Systematic ReviewAmanda E Dilger, Anju T Peters, Richard G Wunderink, et al.
Allergy|September 3, 2015
Five-year risk of incident disease following a diagnosis of chronic rhinosinusitisA G Hirsch, X S Yan, A S Sundaresan, et al.
The American Journal of Cardiology|May 6, 2023
Cardiology Care and Loss to Follow-Up Among Adults With Congenital Heart Defects in CH STRONGJennifer G Andrews, Danielle Strah, Karrie F Downing, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophreniaSean M Smith, Dawn Toolan, Monika Kandebo, et al.
International Forum of Allergy & Rhinology|March 17, 2021
Responsiveness and convergent validity of the chronic rhinosinusitis patient-reported outcome (CRS-PRO) measure in CRS patients undergoing endoscopic sinus surgeryKatherine A Lin, Caroline P E Price, Julia H Huang, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulatorsJeffrey C Kern, Eugene A Terefenko, Andrew Fensome, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 31, 2017
The Clinical Significance of Specific Antibody Deficiency (SAD) Severity in Chronic Rhinosinusitis (CRS)Anjeni Keswani, Neha M Dunn, Angelica Manzur, et al.
Cancer|August 8, 2008
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care centerNarissa J Nonzee, Neal A Dandade, Urjeet Patel, et al.
Pageof 39